Should People be Allowed To Sell Their Organs?
By Alice Park,
Time / CNN
| 07. 03. 2012
How much would it take for you to consider selling your bone marrow? A
U.S. appeals court puts the price at about $3,000 in a ruling that now
makes it legal to pay donors for their bone-marrow tissue.
The court's decision may
well help thousands of sick patients who need bone-marrow transplants to
survive, but it also begs the question, What other body parts might
next be up for sale?
The ruling
came about at the end of 2011, in a decision to an October 2009 lawsuit
brought by a group of cancer patients, parents and bone-marrow-donation
advocates against the government over the federal law banning the
buying and selling of bodily organs. The plaintiffs were led by Doreen
Flynn, who has three daughters who suffer from Fanconi anemia, a blood disorder that requires bone-marrow transplants to treat.
Flynn and the other
plaintiffs said that too many such patients die waiting for transplants
and argued that we should be allowed to pay people to donate their
marrow as a way of ensuring a more reliable supply. The U.S. Court...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...